Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Southern Medical Journal|February 27, 2003
Spontaneous pneumopericardium due to exertionGerald W Westermann, Barbara Suwelack
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 17, 2004
Withdrawal of cyclosporine or tacrolimus after addition of mycophenolate mofetil in patients with chronic allograft nephropathyBarbara Suwelack, Ulf Gerhardt, Helge Hohage
Transplantation Reviews (Orlando, Fla.)|September 24, 2011
The influence of immunosuppressive agents on BK virus risk following kidney transplantation, and implications for choice of regimenBarbara Suwelack, Viola Malyar, Martina Koch, et al.
Current Drug Metabolism|January 5, 2018
Tacrolimus - Pharmacokinetic Considerations for CliniciansKatharina Schutte-Nutgen, Gerold Tholking, Barbara Suwelack, et al.
Scientific Reports|February 13, 2021
Soluble urokinase-type plasminogen activator receptor (suPAR) is a risk indicator for eGFR loss in kidney transplant recipientsUlrich Jehn, Katharina Schütte-Nütgen, Ute Henke, et al.
Journal of Clinical Medicine|January 23, 2020
The Effect of Proton Pump Inhibitor Use on Renal Function in Kidney Transplanted PatientsDominik J G Flothow, Barbara Suwelack, Hermann Pavenstädt, et al.
Scientific Reports|August 4, 2019
Validation of the Kidney Donor Profile Index (KDPI) to assess a deceased donor's kidneys' outcome in a European cohortMaximilian Dahmen, Felix Becker, Hermann Pavenstädt, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 2, 2003
Effect of a 3-year therapy with the 3-hydroxy-3-methylglutaryl coenzyme a reductase-inhibitor fluvastatin on endothelial function and distensibility of large arteries in hypercholesterolemic renal transplant recipientMarkus Kosch, Michael Barenbrock, Barbara Suwelack, et al.
Pageof 8